BILLEV PHARMA ApS: Financial statements 2026
CVR: 81814813
Source: annual report 2026, Danish Business Authority
01/05/2025 – 30/04/2026
BILLEV PHARMA ApS (CVR 81814813) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK 38,801,270 and a net result of DKK 10,205,639 compared with DKK 6,143,854 the year before. That is an increase of 24.4% compared with the year before. Equity in the 2026 report amounted to DKK 10,525,639. The solvency ratio was 66.8%. The company had 24 employees in the financial year.
- Gross Profit
- DKK 38,801,270
- Profit/Loss
- DKK 10,205,639
- Equity
- DKK 10,525,639
- Total Assets
- DKK 15,764,743
- Employees
- 24
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2026 | - | 38.8 mio. | 10.2 mio. | 10.5 mio. | 24 |
| 2025 | - | 31.2 mio. | 6.1 mio. | 6.5 mio. | 21 |
| 2024 | - | 24.8 mio. | 3.4 mio. | 3.7 mio. | 19 |
| 2023 | - | 29.1 mio. | 4.9 mio. | 5.3 mio. | 21 |
| 2022 | - | 30.2 mio. | 6 mio. | 6.3 mio. | 21 |
Official annual report
Find more companies like BILLEV PHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorAbout BILLEV PHARMA ApS
BILLEV PHARMA ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 1977. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Anja Wencke van Arkens and Ulrikke Lynge Jensen. The company is owned by VAN ARKENS HOLDING ApS and UL JENSEN HOLDING ApS. The company has 15 employees (2018). In 2026, the company reported a gross profit of DKK 38,801,270 and a net result of DKK 10,205,639 compared with DKK 6,143,854 the year before. Equity in the 2026 report amounted to DKK 10,525,639.